Abstract:The tumor microbiome, a complex community of microbes found in tumors, has been found to be linked to cancer development, progression, and treatment outcome. However, it remains a bottleneck in distangling the relationship between the tumor microbiome and host gene expressions in tumor microenvironment, as well as their concert effects on patient survival. In this study, we aimed to decode this complex relationship by developing ASD-cancer (autoencoder-based subtypes detector for cancer), a semi-supervised deep learning framework that could extract survival-related features from tumor microbiome and transcriptome data, and identify patients' survival subtypes. By using tissue samples from The Cancer Genome Atlas database, we identified two statistically distinct survival subtypes across all 20 types of cancer Our framework provided improved risk stratification (e.g., for liver hepatocellular carcinoma, [LIHC], log-rank test, P = 8.12E-6) compared to PCA (e.g., for LIHC, log-rank test, P = 0.87), predicted survival subtypes accurately, and identified biomarkers for survival subtypes. Additionally, we identified potential interactions between microbes and host genes that may play roles in survival. For instance, in LIHC, Arcobacter, Methylocella, and Isoptericola may regulate host survival through interactions with host genes enriched in the HIF-1 signaling pathway, indicating these species as potential therapy targets. Further experiments on validation data sets have also supported these patterns. Collectively, ASD-cancer has enabled accurate survival subtyping and biomarker discovery, which could facilitate personalized treatment for broad-spectrum types of cancers.IMPORTANCEUnraveling the intricate relationship between the tumor microbiome, host gene expressions, and their collective impact on cancer outcomes is paramount for advancing personalized treatment strategies. Our study introduces ASD-cancer, a cutting-edge autoencoder-based subtype detector. ASD-cancer decodes the complexities within the tumor microenvironment, successfully identifying distinct survival subtypes across 20 cancer types. Its superior risk stratification, demonstrated by significant improvements over traditional methods like principal component analysis, holds promise for refining patient prognosis. Accurate survival subtype predictions, biomarker discovery, and insights into microbe-host gene interactions elevate ASD-cancer as a powerful tool for advancing precision medicine. These findings not only contribute to a deeper understanding of the tumor microenvironment but also open avenues for personalized interventions across diverse cancer types, underscoring the transformative potential of ASD-cancer in shaping the future of cancer care.

Dynamic Meta-data Network Sparse PCA for Cancer Subtype Biomarker Screening

Using feature selection and Bayesian network identify cancer subtypes based on proteomic data

Supervised Discriminative Sparse PCA for Com-Characteristic Gene Selection and Tumor Classification on Multiview Biological Data

A Dynamic Subspace Learning Method for Tumor Classification Using Microarray Gene Expression Data

MM-DCNet: A Multi-Scale and Multi-MOdality Dynamic Convolutional Network for Lung Cancer Subtypes Classification

Integrating Multi-Omic Data with Deep Subspace Fusion Clustering for Cancer Subtype Prediction

Deep Subspace Mutual Learning for Cancer Subtypes Prediction

Deep Learning Enabled Integration of Tumor Microenvironment Microbial Profiles and Host Gene Expressions for Interpretable Survival Subtyping in Diverse Types of Cancers.

Multi-Omics Data Fusion via a Joint Kernel Learning Model for Cancer Subtype Discovery and Essential Gene Identification

Cancer Classification Using Microarray Data by DPCAForest

Molecular Subtyping of Cancer Based on Distinguishing Co-Expression Modules and Machine Learning

PCA via joint graph Laplacian and sparse constraint: Identification of differentially expressed genes and sample clustering on gene expression data

PCA-constrained multi-core matrix fusion network: A novel approach for cancer subtype identification

Utilizing tumor microenvironment microbial profiles and host gene expressions for survival subtyping in diverse types of cancers

Cancer Subtype Discovery and Biomarker Identification Via a New Robust Network Clustering Algorithm.

Multi-scale supervised clustering-based feature selection for tumor classification and identification of biomarkers and targets on genomic data

PACS: Prediction and analysis of cancer subtypes from multi-omics data based on a multi-head attention mechanism model

RamanMicrospectral Study and Classification of the Pathological Evolution of Breast Cancer Using Both Principal Component Analysis-Linear Discriminant Analysis and Principal Component Analysis-Support Vector Machine

Subtype-DCC: decoupled contrastive clustering method for cancer subtype identification based on multi-omics data

Latent space search based multimodal optimization with personalized edge-network biomarker for multi-purpose early disease prediction

Supervised clustering of high-dimensional data using regularized mixture modeling